{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:29:32Z","timestamp":1781843372788,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"crossref","award":["MNmb 18"],"award-info":[{"award-number":["MNmb 18"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00213-018-4940-6","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T04:29:46Z","timestamp":1528345786000},"page":"2423-2434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Withdrawal of caffeine after its chronic administration modifies the antidepressant-like activity of atypical antidepressants in mice. Changes in cortical expression of Comt, Slc6a15 and Adora1 genes"],"prefix":"10.1007","volume":"235","author":[{"given":"Aleksandra","family":"Szopa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Doboszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Herbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"\u015awi\u0105der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Korga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ostrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ju\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szymon","family":"Jedynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Dudka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"4940_CR1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington","edition":"5"},{"key":"4940_CR2","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/j.neubiorev.2013.06.006","volume":"37","author":"N Antypa","year":"2013","unstructured":"Antypa N, Drago A, Serretti A (2013) The role of COMT gene variants in depression: bridging neuropsychological, behavioral and clinical phenotypes. Neurosci Biobehav Rev 37:1597\u20131610","journal-title":"Neurosci Biobehav Rev"},{"key":"4940_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/bmc.736","volume":"21","author":"E Begas","year":"2007","unstructured":"Begas E, Kouvaras E, Tsakalof A, Papakosta S, Asprodini EK (2007) In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios. Biomed Chromatogr 21:190\u2013200","journal-title":"Biomed Chromatogr"},{"key":"4940_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1146\/annurev.me.41.020190.001425","volume":"41","author":"NL Benowitz","year":"1990","unstructured":"Benowitz NL (1990) Clinical pharmacology of caffeine. Annu Rev Med 41:277\u2013288","journal-title":"Annu Rev Med"},{"key":"4940_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/0006-3223(93)90121-S","volume":"33","author":"G Biagini","year":"1993","unstructured":"Biagini G, Pich EM, Carani C, Marrama P, Gustafsson JA, Fuxe K, Agnati LF (1993) Indole-pyruvic acid, a tryptophan ketoanalogue, antagonizes the endocrine but not the behavioral effects of repeated stress in a model of depression. Biol Psychiatry 33:712\u2013719","journal-title":"Biol Psychiatry"},{"key":"4940_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1042\/BJ20051273","volume":"393","author":"A Broer","year":"2006","unstructured":"Broer A, Tietze N, Kowalczuk S, Chubb S, Munzinger M, Bak LK, Broer S (2006) The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2). Biochem J 393:421\u2013430","journal-title":"Biochem J"},{"key":"4940_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11302-015-9446-7","volume":"11","author":"MP Cunha","year":"2015","unstructured":"Cunha MP, Pazini FL, Rosa JM, Ramos-Hryb AB, Oliveira A, Kaster MP, Rodrigues AL (2015) Creatine, similarly to ketamine, affords antidepressant-like effects in the tail suspension test via adenosine A1 and A2A receptor activation. Purinergic Signal 11:215\u2013227","journal-title":"Purinergic Signal"},{"key":"4940_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/clpt.1990.150","volume":"48","author":"CP Denaro","year":"1990","unstructured":"Denaro CP, Brown CR, Wilson M, Jacob P III, Benowitz NL (1990) Dose-dependency of caffeine metabolism with repeated dosing. Clin Pharmacol Ther 48:277\u2013285","journal-title":"Clin Pharmacol Ther"},{"key":"4940_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S0278-6915(02)00095-9","volume":"40","author":"PB Dews","year":"2002","unstructured":"Dews PB, O\u2019Brien CP, Bergman J (2002) Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol 40:1257\u20131261","journal-title":"Food Chem Toxicol"},{"key":"4940_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56:331\u2013349","journal-title":"Pharmacol Rev"},{"key":"4940_CR11","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1073\/pnas.1614677114","volume":"114","author":"D Elmenhorst","year":"2017","unstructured":"Elmenhorst D, Elmenhorst EM, Hennecke E, Kroll T, Matusch A, Aeschbach D, Bauer A (2017) Recovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain. Proc Natl Acad Sci U S A 114:4243\u20134248","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4940_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1006\/geno.2000.6387","volume":"70","author":"MK Farmer","year":"2000","unstructured":"Farmer MK, Robbins MJ, Medhurst AD, Campbell DA, Ellington K, Duckworth M, Brown AM, Middlemiss DN, Price GW, Pangalos MN (2000) Cloning and characterization of human NTT5 and v7-3: two orphan transporters of the Na+\/Cl\u2212-dependent neurotransmitter transporter gene family. Genomics 70:241\u2013252","journal-title":"Genomics"},{"key":"4940_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.mam.2016.11.011","volume":"55","author":"BB Fredholm","year":"2016","unstructured":"Fredholm BB, Yang J, Wang Y (2016) Low, but not high, dose caffeine is a readily available probe for adenosine actions. Mol Asp Med 55:20\u201325","journal-title":"Mol Asp Med"},{"key":"4940_CR14","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/hup.964","volume":"23","author":"A Germain","year":"2008","unstructured":"Germain A, Kupfer DJ (2008) Circadian rhythm disturbances in depression. Hum Psychopharmacol 23:571\u2013585","journal-title":"Hum Psychopharmacol"},{"key":"4940_CR15","doi-asserted-by":"publisher","first-page":"9991","DOI":"10.1073\/pnas.95.17.9991","volume":"95","author":"JA Gogos","year":"1998","unstructured":"Gogos JA, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci U S A 95:9991\u20139996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4940_CR16","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.1111\/bph.12720","volume":"171","author":"B Guardiola-Lemaitre","year":"2014","unstructured":"Guardiola-Lemaitre B, De Bodinat C, Delagrange P, Millan MJ, Munoz C, Moca\u00ebr E (2014) Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties. Br J Pharmacol 171:3604\u20133619","journal-title":"Br J Pharmacol"},{"key":"4940_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2202-14-54","volume":"14","author":"MG Hagglund","year":"2013","unstructured":"Hagglund MG, Hellsten SV, Bagchi S, Ljungdahl A, Nilsson VC, Winnergren S, Stephansson O, Rumaks J, Svirskis S, Klusa V, Schioth HB, Fredriksson R (2013) Characterization of the transporter B0AT3 (Slc6a17) in the rodent central nervous system. BMC Neurosci 14:54\u201314","journal-title":"BMC Neurosci"},{"key":"4940_CR18","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1111\/j.1750-3841.2010.01561.x","volume":"75","author":"MA Heckman","year":"2010","unstructured":"Heckman MA, Weil J, Gonzalez De Mejia E (2010) Caffeine (1,3,7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 75:R77\u2013R87","journal-title":"J Food Sci"},{"key":"4940_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-004-2000-x","volume":"176","author":"LM Juliano","year":"2004","unstructured":"Juliano LM, Griffiths RR (2004) A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology 176:1\u201329","journal-title":"Psychopharmacology"},{"key":"4940_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.pbb.2014.06.005","volume":"124","author":"PP Kale","year":"2014","unstructured":"Kale PP, Addepalli V (2014) Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice. Pharmacol Biochem Behav 124:238\u2013244","journal-title":"Pharmacol Biochem Behav"},{"key":"4940_CR21","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1046\/j.1471-4159.1994.63030972.x","volume":"63","author":"F Karoum","year":"1994","unstructured":"Karoum F, Chrapusta SJ, Egan MF (1994) 3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model. J Neurochem 63:972\u2013979","journal-title":"J Neurochem"},{"key":"4940_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuron.2011.04.005","volume":"70","author":"MA Kohli","year":"2011","unstructured":"Kohli MA, Lucae S, Saemann PG, Schmidt MV, Demirkan A, Hek K, Czamara D, Alexander M, Salyakina D, Ripke S, Hoehn D, Specht M, Menke A, Hennings J, Heck A, Wolf C, Ising M, Schreiber S, Czisch M, M\u00fcller MB, Uhr M, Bettecken T, Becker A, Schramm J, Rietschel M, Maier W, Bradley B, Ressler KJ, N\u00f6then MM, Cichon S, Craig IW, Breen G, Lewis CM, Hofman A, Tiemeier H, van Duijn CM, Holsboer F, M\u00fcller-Myhsok B, Binder EB (2011) The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 70:252\u2013265","journal-title":"Neuron"},{"key":"4940_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jad.2017.12.044","volume":"229","author":"S Koike","year":"2018","unstructured":"Koike S, Gaysina D, Jones PB, Wong A, Richards M (2018) Catechol O-methyltransferase (COMT) functional haplotype is associated with recurrence of affective symptoms: a prospective birth cohort study. J Affect Disord 229:437\u2013442","journal-title":"J Affect Disord"},{"key":"4940_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1124\/pr.108.000869","volume":"63","author":"AS Kristensen","year":"2011","unstructured":"Kristensen AS, Andersen J, J\u00f8rgensen TN, S\u00f8rensen L, Eriksen J, Loland CJ, Str\u00f8mgaard K, Gether U (2011) SLC6 neurotransmitter transporters: structure, function, and regulation. Pharmacol Rev 63:585\u2013640","journal-title":"Pharmacol Rev"},{"key":"4940_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1176\/ajp.150.2.294","volume":"150","author":"E Leibenluft","year":"1993","unstructured":"Leibenluft E, Fiero PL, Bartko JJ, Moul DE, Rosenthal NE (1993) Depressive symptoms and the self-reported use of alcohol, caffeine, and carbohydrates in normal volunteers and four groups of psychiatric outpatients. Am J Psychiatry 150:294\u2013301","journal-title":"Am J Psychiatry"},{"key":"4940_CR26","first-page":"10","volume":"61","author":"QS Liu","year":"2017","unstructured":"Liu QS, Deng R, Fan Y, Li K, Meng F, Li X, Liu R (2017) Low dose of caffeine enhances the efficacy of antidepressants in major depressive disorder and the underlying neural substrates. Mol Nutr Food Res 61:10","journal-title":"Mol Nutr Food Res"},{"key":"4940_CR27","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/archinternmed.2011.393","volume":"171","author":"M Lucas","year":"2011","unstructured":"Lucas M, Mirzaei F, Pan A, Okereke OI, Willett WC, O\u2019Reilly EJ, Koenen K, Ascherio A (2011) Coffee, caffeine, and risk of depression among women. Arch Intern Med 171:1571\u20131578","journal-title":"Arch Intern Med"},{"key":"4940_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0008566","volume":"5","author":"L Musazzi","year":"2010","unstructured":"Musazzi L, Milanese M, Farisello P, Zappettini S, Tardito D, Barbiero VS, Bonifacino T, Mallei A, Baldelli P, Racagni G, Raiteri M, Benfenati F, Bonanno G, Popoli M (2010) Acute stress increases depolarization-evoked glutamate release in the rat prefrontal\/frontal cortex: the dampening action of antidepressants. PLoS One 5:e8566","journal-title":"PLoS One"},{"key":"4940_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0165-0173(92)90012-B","volume":"17","author":"A Nehlig","year":"1992","unstructured":"Nehlig A, Daval JL, Debry G (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Brain Res Rev 17:139\u2013170","journal-title":"Brain Res Brain Res Rev"},{"key":"4940_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3103\/S0027131413010082","volume":"68","author":"YG Novitskayaa","year":"2013","unstructured":"Novitskayaa YG, Litvina AA, Zherdeva VP, Blynskayaa EV, Kondabov KS (2013) Assay of caffeine and its metabolites in the rat blood plasma using HPLC as a method for determination of metabolic ratios.\u00a0Moscow Univ Chem Bull 68:47\u201350","journal-title":"Moscow Univ Chem Bull"},{"key":"4940_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pbb.2013.10.015","volume":"123","author":"OF O\u2019Leary","year":"2014","unstructured":"O\u2019Leary OF, O\u2019Brien FE, O\u2019Connor RM, Cryan JF (2014) Drugs, genes and the blues: pharmacogenetics of the antidepressant response from mouse to man. Pharmacol Biochem Behav 123:55\u201376","journal-title":"Pharmacol Biochem Behav"},{"key":"4940_CR32","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/bmb\/lds004","volume":"101","author":"E Palazidou","year":"2012","unstructured":"Palazidou E (2012) The neurobiology of depression. Br Med Bull 101:127\u2013145","journal-title":"Br Med Bull"},{"key":"4940_CR33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.biopsych.2013.01.021","volume":"73","author":"A Pilc","year":"2013","unstructured":"Pilc A, Wiero\u0144ska JM, Skolnick P (2013) Glutamate-based antidepressants: preclinical psychopharmacology. Biol Psychiatry 73:1125\u20131132","journal-title":"Biol Psychiatry"},{"key":"4940_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.pharep.2015.06.138","volume":"68","author":"E Poleszak","year":"2016","unstructured":"Poleszak E, Szopa A, Wyska E, Kuku\u0142a-Koch W, Serefko A, Wo\u015bko S, Bogatko K, Wr\u00f3bel A, Wla\u017a P (2016) Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice. Pharmacol Rep 68:56\u201361","journal-title":"Pharmacol Rep"},{"key":"4940_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.lfs.2015.06.008","volume":"136","author":"E Poleszak","year":"2015","unstructured":"Poleszak E, Szopa A, Wyska E, Wo\u015bko S, Serefko A, Wla\u017a A, Pier\u00f3g M, Wr\u00f3bel A, Wla\u017a P (2015) The influence of caffeine on the activity of moclobemide, venlafaxine, bupropion and milnacipran in the forced swim test in mice. Life Sci 136:13\u201318","journal-title":"Life Sci"},{"key":"4940_CR36","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1016\/j.pnpbp.2011.03.005","volume":"35","author":"S Porcelli","year":"2011","unstructured":"Porcelli S, Drago A, Fabbri C, Serretti A (2011) Mechanisms of antidepressant action: an integrated dopaminergic perspective. Prog Neuro-Psychopharmacol Biol Psychiatry 35:1532\u20131543","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"4940_CR37","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"Suppl","key":"4940_CR38","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1007\/BF02246238","volume":"106","author":"JG Ramaekers","year":"1992","unstructured":"Ramaekers JG, Swijgman HF, O\u2019Hanlon JF (1992) Effects of moclobemide and mianserin on highway driving, psychometric performance and subjective parameters, relative to placebo. Psychopharmacology 106(Suppl):S62\u2013S67","journal-title":"Psychopharmacology"},{"key":"4940_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.apcsb.2015.10.003","volume":"103","author":"GZ Reus","year":"2016","unstructured":"Reus GZ, Abelaira HM, Tuon T, Titus SE, Ignacio ZM, Rodrigues AL, Quevedo J (2016) Glutamatergic NMDA receptor as therapeutic target for depression. Adv Protein Chem Struct Biol 103:169\u2013202","journal-title":"Adv Protein Chem Struct Biol"},{"key":"4940_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/BF02274898","volume":"246","author":"M Rihs","year":"1996","unstructured":"Rihs M, Muller C, Baumann P (1996) Caffeine consumption in hospitalized psychiatric patients. Eur Arch Psychiatry Clin Neurosci 246:83\u201392","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"4940_CR41","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1017\/S1368980010000509","volume":"13","author":"A Ruusunen","year":"2010","unstructured":"Ruusunen A, Lehto SM, Tolmunen T, Mursu J, Kaplan GA, Voutilainen S (2010) Coffee, tea and caffeine intake and the risk of severe depression in middle-aged Finnish men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Public Health Nutr 13:1215\u20131220","journal-title":"Public Health Nutr"},{"key":"4940_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/10253890.2015.1105211","volume":"19","author":"S Santarelli","year":"2016","unstructured":"Santarelli S, Wagner KV, Labermaier C, Uribe A, Dournes C, Balsevich G, Hartmann J, Masana M, Holsboer F, Chen A, M\u00fcller MB, Schmidt MV (2016) SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system. Stress 19:83\u201390","journal-title":"Stress"},{"key":"4940_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/978-3-540-89615-9_16","volume":"193","author":"AM Sebasti\u00e3o","year":"2009","unstructured":"Sebasti\u00e3o AM, Ribeiro JA (2009) Adenosine receptors and the central nervous system. Handb Exp Pharmacol 193:471\u2013534","journal-title":"Handb Exp Pharmacol"},{"key":"4940_CR44","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.neuron.2015.07.010","volume":"87","author":"T Serchov","year":"2015","unstructured":"Serchov T, Clement HW, Schwarz MK, Iasevoli F, Tosh DK, Idzko M, Jacobson KA, de Bartolomeis A, Normann C, Biber K, van Calker D (2015) Increased signaling via adenosine A1 receptors, sleep deprivation, imipramine, and ketamine inhibit depressive-like behavior via induction of Homer1a. Neuron 87:549\u2013562","journal-title":"Neuron"},{"key":"4940_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"4940_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.taap.2017.10.020","volume":"337","author":"A Szopa","year":"2017","unstructured":"Szopa A, Doboszewska U, Herbet M, Wo\u015bko S, Wyska E, \u015awi\u0105der K, Serefko A, Korga A, Wla\u017a A, Wr\u00f3bel A, Ostrowska M, Terlecka J, Kanadys A, Poleszak E, Dudka J, Wla\u017a P (2017) Chronic treatment with caffeine and its withdrawal modify the antidepressant-like activity of ve serotonin reuptake inhibitors in the forced swim and tail suspension tests in mice. Effects on Comt, Slc6a15 and Adora1 gene expression. Toxicol Appl Pharmacol 337:95\u2013103","journal-title":"Toxicol Appl Pharmacol"},{"key":"4940_CR47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00210-015-1189-z","volume":"389","author":"A Szopa","year":"2016","unstructured":"Szopa A, Poleszak E, Wyska E, Serefko A, Wo\u015bko S, Wla\u017a A, Pier\u00f3g M, Wr\u00f3bel A, Wla\u017a P (2016) Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn Schmiedeberg\u2019s Arch Pharmacol 389:211\u2013221","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"Suppl 3","key":"4940_CR48","doi-asserted-by":"publisher","first-page":"S482","DOI":"10.1016\/j.euroneuro.2012.06.016","volume":"22","author":"D Tardito","year":"2012","unstructured":"Tardito D, Molteni R, Popoli M, Racagni G (2012) Synergistic mechanisms involved in the antidepressant effects of agomelatine. Eur Neuropsychopharmacol 22(Suppl 3):S482\u2013S486","journal-title":"Eur Neuropsychopharmacol"},{"key":"4940_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1124\/pr.58.1.7","volume":"58","author":"D Tardito","year":"2006","unstructured":"Tardito D, Perez J, Tiraboschi E, Musazzi L, Racagni G, Popoli M (2006) Signaling pathways regulating gene expression, neuroplasticity, and neurotrophic mechanisms in the action of antidepressants: a critical overview. Pharmacol Rev 58:115\u2013134","journal-title":"Pharmacol Rev"},{"key":"4940_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M (2006) Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163:28\u201340","journal-title":"Am J Psychiatry"},{"key":"4940_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/syn.21732","volume":"68","author":"EM Tsapakis","year":"2014","unstructured":"Tsapakis EM, Fernandes C, Moran-Gates T, Basu A, Sugden K, Aitchison KJ, Tarazi FI (2014) Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex. Synapse 68:209\u2013220","journal-title":"Synapse"},{"key":"4940_CR52","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1432-1033.1997.0452a.x","volume":"243","author":"I Ulmanen","year":"1997","unstructured":"Ulmanen I, Per\u00e4nen J, Tenhunen J, Tilgmann C, Karhunen T, Panula P, Bernasconi L, Aubry JP, Lundstr\u00f6m K (1997) Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells. Eur J Biochem 243:452\u2013459","journal-title":"Eur J Biochem"},{"key":"4940_CR53","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/sj.npp.1301143","volume":"32","author":"TI Uzbay","year":"2007","unstructured":"Uzbay TI, Kayir H, Ceyhan M (2007) Effects of tianeptine on onset time of pentylenetetrazole-induced seizures in mice: possible role of adenosine A1 receptors. Neuropsychopharmacology 32:412\u2013416","journal-title":"Neuropsychopharmacology"},{"key":"4940_CR54","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11481-016-9651-3","volume":"11","author":"M Wang","year":"2016","unstructured":"Wang M, Ma Y, Yuan W, Su K, Li MD (2016) Meta-analysis of the COMT Val158Met polymorphism in major depressive disorder: effect of ethnicity. J NeuroImmune Pharmacol 11:434\u2013445","journal-title":"J NeuroImmune Pharmacol"},{"key":"4940_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11920-017-0816-4","volume":"19","author":"A Wichniak","year":"2017","unstructured":"Wichniak A, Wierzbicka A, Walecka M, Jernajczyk W (2017) Effects of antidepressants on sleep. Curr Psychiatry Rep 19:63","journal-title":"Curr Psychiatry Rep"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-4940-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4940-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T19:04:33Z","timestamp":1559847873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-4940-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4940"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-4940-6","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"22 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures were conducted in accordance with the European Communities Council Directive of 22 September 2010 (2010\/63\/EU) and Polish legislation acts concerning animal experimentations. The experimental procedures and protocols were approved by the First Local Ethics Committee at the Medical University of Lublin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}